ArticleScientific reports2024
Interfacial tension reduction using nitrogen graphene quantum dots with various precursors, molar ratios, and synthesis durations for enhanced oil recovery.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Nitrogen-Doped Graphene Quantum Dots Conjugated to Leucettinib-21 Rescue Differentiating Zebrafish Purkinje Cells by Inhibiting Dyrk1A Kinase.ACS applied nano materials · 2026Article
- Pioneering oil and nitrogen interfacial tension using evolutionarily optimized gradient boosting machine.Scientific reports · 2026Article
- Study on the Dual Enhancement Effect of Nanoparticle-Surfactant Composite Systems on Oil Recovery Rates.Nanomaterials (Basel, Switzerland) · 2026Article
- Evaluating the role of monovalent and divalent salts on interfacial tension reduction using nitrogen doped carbon dots for enhanced oil recovery.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanofluids have the capacity to reduce interfacial tension (IFT) of crude oil and water for enhanced oil recovery (EOR) operations, but traditional nanoparticles are limited in tight reservoirs due to their inappropriate size for micro-nano pores and their tendency to aggregate. In this paper, Graphene Quantum Dots (GQDs) with simple and favorable properties are developed, and their performance and mechanism for reducing IFT are evaluated. The paper also aims to explore the effects of GQD precursor type, synthesis duration, and molar percentages of precursors on reducing IFT. For this purpose, citric acid was used as a carbon source, and ethylenediamine, urea, and thiourea were used as nitrogen sources to synthesize different GQDs. FTIR, XPS, HR-TEM, XRD, UV visible, and PL photoluminescence were used to identify the GQDs' characteristics. The highest IFT reduction value is achieved by using 1000 ppm ethylenediamine-derived GQDs, which reduces the IFT from 19.03 to 0.70 mN/m at 200,000 ppm NaCl concentrations without using any surfactants. The XPS analysis revealed that ethylenediamine-derived GQDs exhibit higher pyrrolic nitrogen content and a relative intensity ratio of sp3 C/sp2 C. It has been identified that the presence of more polar atomic bonds on the surfaces of GQDs decreases the ability of GQDs to reduce IFT. In this way, urea-derived and thiourea-derived GQDs exhibit less capability for IFT reductions from 19.03 to 12.33 and 18.04 mN/m at 1000 ppm GQDs and 200,000 ppm NaCl concentration, respectively. Furthermore, ethylenediamine-derived and urea-derived GQDs perform optimally at approximately 5 and 10 h, respectively, with a precursor molar ratio of 3 (mole ethylenediamine/urea per mole citric acid), while thiourea-derived GQDs show no significant IFT change with varying synthesis times or precursor molar ratio. The developed GQDs provide a promising solution for EOR operations in unconventional reservoirs by significantly decreasing the IFT between crude oil and nanofluids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.